Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Roecker

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Urology|August 1, 1992
Home screening for hematuria: results of a multiclinic studyE M Messing, T B Young, V B Hunt, et al.
Transplantation Proceedings|February 1, 1991
Predictive factors for immunologic graft failure in cadaver renal transplant recipientsJ D Pirsch, B J Voss, E B Roecker, et al.
The New England Journal of Medicine|June 2, 2001
Effect of carvedilol on survival in severe chronic heart failureM Packer, A J Coats, M B Fowler, et al.
The New England Journal of Medicine|May 4, 2000
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic EventsW W O'Neill, P Serruys, M Knudtson, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Urology|August 1, 1992
Home screening for hematuria: results of a multiclinic studyE M Messing, T B Young, V B Hunt, et al.
Transplantation Proceedings|February 1, 1991
Predictive factors for immunologic graft failure in cadaver renal transplant recipientsJ D Pirsch, B J Voss, E B Roecker, et al.
The New England Journal of Medicine|June 2, 2001
Effect of carvedilol on survival in severe chronic heart failureM Packer, A J Coats, M B Fowler, et al.
The New England Journal of Medicine|May 4, 2000
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic EventsW W O'Neill, P Serruys, M Knudtson, et al.
Pageof 4